Published July 17, 2021
| Version v1
Journal article
Restricted
Commentary: Mending a broken heart: The ongoing quest for mesenchymal stem cell therapy for ischemic cardiomyopathy
Authors/Creators
- 1. Istituto di Ricovero e Cura a Carattere Scientifico MultiMedica, Milan, Italy
- 2. Division of Cardiology, University of Perugia School of Medicine, Perugia, Italy
Description
CENTRAL MESSAGE: Future success of MSC therapy for ischemic cardiomyopathy may depend on an integrated approach, boosting regenerative cell function while tailoring therapy to the receiving patient’s background.